Seeking Alpha

Targacept (TRGT) -15% premarket after the antidepressant it was testing with AstraZeneca (AZN)...

Targacept (TRGT) -15% premarket after the antidepressant it was testing with AstraZeneca (AZN) failed in its last two late-stage studies, ending plans to seek regulatory approval. The two companies said on Dec. 20 the drug hadn’t met its target in a late-stage trial, and the latest failure was the final of four trials on the therapy.
Comments (0)
Be the first to comment
DJIA (DIA) S&P 500 (SPY)
ETF Hub
ETF Screener: Search and filter by asset class, strategy, theme, performance, yield, and much more
ETF Performance: View ETF performance across key asset classes and investing themes
ETF Investing Guide: Learn how to build and manage a well-diversified, low cost ETF portfolio
ETF Selector: An explanation of how to select and use ETFs